Managing late complications of Parkinson's disease

被引:13
|
作者
Stacy, M [1 ]
机构
[1] Barrow Neurol Inst, Muhammad Ali Parkinson Ctr, Phoenix, AZ 85213 USA
关键词
D O I
10.1016/S0025-7125(05)70114-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment of parkinsonism becomes more difficult as the disease progresses, and results from increasing neuronal degeneration, side effects from antiparkinsonian medications, or most often, a combination of each. Neurodegenerative parkinson symptoms may result from substantia ni,ora destruction, or from other areas in the nervous system. These include the cortex (cognitive and psychiatric disorders), brainstem (bulbar abnormalities), intermediolateral cell column (autonomic disturbances), among others. Medication side effects produce motor fluctuations, dyskinesias, delirium, hallucinations, psychosis, orthostatic hypotension, sleep disorders, and a host of other well-recognized complications. This article is divided into sections concerning motor fluctuations, gait difficulty bulbar disturbances, autonomic disturbances, sleep disorders, cognitive disorders, and psychiatric disorders, and is an attempt to provide the reader with strategies for treating common complications in the advanced Parkinson's disease patient.
引用
收藏
页码:469 / +
页数:14
相关论文
共 50 条
  • [21] Postoperative complications in Parkinson's disease
    Pepper, PV
    Goldstein, MK
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (08) : 967 - 972
  • [22] Respiratory complications of Parkinson's disease
    Shill, H
    Stacy, M
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 23 (03) : 261 - 265
  • [23] Psychiatric complications in Parkinson's disease
    Wolters, EC
    ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 8, 2000, 8 : 291 - 302
  • [24] Understanding complications of Parkinson's disease
    Stoessl, AJ
    MOVEMENT DISORDERS, 2002, 17 : S6 - S7
  • [25] Managing Parkinson's disease: moving ON with NOP
    Mercatelli, Daniela
    Bezard, Erwan
    Eleopra, Roberto
    Zaveri, Nurulain T.
    Morari, Michele
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (01) : 28 - 47
  • [26] Managing the neuropsychiatric symptoms of Parkinson's disease
    Lieberman, A
    NEUROLOGY, 1998, 50 (06) : S33 - S38
  • [27] The challenge of managing mild Parkinson's disease
    LeWitt, PA
    PHARMACOTHERAPY, 2000, 20 (01): : 2S - 7S
  • [28] Pharmacologic options for managing Parkinson's disease
    Evidente, VGH
    Adler, CH
    FORMULARY, 1997, 32 (06) : 594 - +
  • [29] COST OF MANAGING PARKINSON'S DISEASE IN CHINA
    Low, W.
    Azmi, S.
    Hansen, K.
    Francois, C.
    Milea, D.
    VALUE IN HEALTH, 2014, 17 (03) : A59 - A59
  • [30] Managing psychosis in patients with Parkinson's disease
    Cummings, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10): : 801 - 803